Clinical Safety and Efficacy of Nilotinib or Dasatinib in Patients With Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia and Pre-Existing Liver and/or Renal Dysfunction
Author:
Funder
National Cancer Institute
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference26 articles.
1. AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, has in vitro activity against imatinib-resistant chronic myeloid leukemia;Golemovic;Clin Cancer Res,2005
2. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl;Weisberg;Cancer Cell,2005
3. Overriding imatinib resistance with a novel ABL kinase inhibitor;Shah;Science,2004
4. Nilotinib as front-line treatment for patients with chronic myeloid leukemia in early chronic phase;Cortes;J Clin Oncol,2010
5. Nilotinib for the frontline treatment of Ph(+) chronic myeloid leukemia;Rosti;Blood,2009
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13‐Mediated Stabilization of Bcl‐XL;Advanced Science;2023-07-14
2. Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management;Signal Transduction and Targeted Therapy;2023-07-07
3. Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer;Cancers;2023-03-14
4. Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an option;Blood Reviews;2022-11
5. Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia;Frontiers in Oncology;2022-10-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3